XML 38 R26.htm IDEA: XBRL DOCUMENT v3.23.4
ACQUISITIONS AND DISPOSITIONS (Tables)
 9 Months Ended
Sep. 30, 2023
Acquisitions And Dispositions  
SCHEDULE OF PURCHASE PRICE ALLOCATION

The provisional Amended Purchase Price allocation as of the acquisition date is presented as follows:

 

   July 31, 2023 
Purchase consideration:     
Common Stock, at fair value  $996,019 
Series B Preferred Stock, at fair value   11,504,070 
Total purchase consideration  $12,500,089 
      
Purchase price allocation:     
Cash  $5,546 
Prepaid expenses   3,705 
Inventory   122,792 
Intangible assets, net   9,777,478 
Goodwill   5,129,116 
Assets acquired   15,038,637 
Accounts payable and other current liabilities   (633,548)
Notes payable   (1,905,000)
Liabilities assumed   (2,538,548)
Net assets acquired  $12,500,089 
SCHEDULE OF FAIR VALUES OF ASSETS ACQUIRED

The following summarizes the provisional relative fair values of the assets acquired as of the acquisition date based on the allocation of the cost of the asset acquisition:

 

   September 27, 2023 
Purchase consideration:     
Promissory note  $3,150,000 
Total purchase consideration  $3,150,000 
      
Allocation of cost of assets acquired:     
Inventory  $2,960,235 
Property and equipment   231,170 
Operating right-of-use assets   383,218 
Assets acquired   3,574,623 
Liabilities assumed   (424,623)
Net assets acquired  $3,150,000 
SCHEDULE OF FINANCIAL STATEMENTS OF DISCONTINUED OPERATIONS

 

   September 30, 2023   December 31, 2022 
         
Cash  $-   $22,474 
Accounts receivable   -    363 
Total assets of discontinued operations  $-   $22,837 
           
Accounts payable  $-   $46,500 
Total liabilities of discontinued operations  $-   $46,500 
SCHEDULE OF ASSETS AND LIABILITIES

As a result of the transactions, the following assets and liabilities of APS and CSP were transferred to Wood Sage as of August 22, 2023:

 SCHEDULE OF ASSETS AND LIABILITIES

   Alliance Pharma Solutions, LLC   Community Specialty Pharmacy, LLC 
Cash  $1,050   $61,988 
Accounts receivable, net   -    11,452 
Inventory   -    123,230 
Prepaid assets   -    525 
Intangible assets and capitalized software, net   739,337    - 
Accounts payable   (23,982)   (231,876)
Accrued liabilities   -    (10,182)
Net assets sold  $716,405   $(44,863)
SCHEDULE OF DISCONTINUED OPERATIONS

SCHEDULE OF DISCONTINUED OPERATIONS

 

   2023   2022   2023   2022   2023   2022   2023   2022 
   SOSRx   APS   CSP   Total 
   Three Months Ended September 30,   Three Months Ended September 30,   Three Months Ended September 30,   Three Months Ended September 30, 
   2023   2022   2023   2022   2023   2022   2023   2022 
Revenue  $-   $3,368   $-   $-   $124,238   $341,140   $124,238   $344,508 
Cost of sales   -    -    -    -    127,671    314,945    127,671    314,945 
Gross profit   -    3,368    -    -    (3,433)   26,195    (3,433)   29,563 
                                         
Operating expenses                                        
Wage and salary expense   -    17,689    -    -    108,772    70,002    108,772    87,691 
Professional fees   -    -    -    10,471    18,079    2,094    18,079    12,565 
Accounting and legal expense   -    -    1,948    104    700    500    2,648    604 
Technology expense   -    23,000    4,177    31,564    2,231    5,445    6,408    60,009 
General and administrative   -    29,907    134    3,527    4,257    25,428    4,391    58,862 
Total operating expense   -    70,596    6,259    45,666    134,039    103,469    140,298    219,731 
                                         
Operating loss from discontinued operations   -    (67,228)   (6,259)   (45,666)   (137,472)   (77,274)   (143,731)   (190,168)
                                         
Other income (expense)                                        
Gain (loss) on disposal of assets   -    -    (1,783,209)   1,900    (1,426,567)   -    (3,209,776)   1,900 
Total other income (expense)   -    -    (1,783,209)   1,900    (1,426,567)   -    (3,209,776)   1,900 
                                         
Loss from discontinued operations  $-   $(67,228)  $(1,789,468)  $(43,766)  $(1,564,039)  $(77,274)  $(3,353,507)  $(188,268)
                                         
Loss per common share from discontinued operations                                        
Basic  $-   $(0.12)  $(2.32)  $(0.08)  $(2.03)  $(0.14)  $(4.35)  $(0.34)
Diluted  $-   $(0.12)  $(0.76)  $(0.08)  $(0.66)  $(0.14)  $(1.42)  $(0.34)

 

 

   2023   2022   2023   2022   2023   2022   2023   2022 
   SOSRx   ASP   CSP   Total 
   Nine months ended September 30,   Nine months ended September 30,   Nine months ended September 30,   Nine months ended September 30, 
   2023   2022   2023   2022   2023   2022   2023   2022 
Revenue  $-   $20,424   $-   $-   $761,306   $905,083   $761,306   $925,507 
Cost of sales   -    -    -    -    705,206    1,019,470    705,206    1,019,470 
Gross profit   -    20,424    -    -    56,100    (114,387)   56,100    (93,963)
                                         
Operating expenses                                        
Wage and salary expense   -    54,939    -    -    456,297    180,819    456,297    235,758 
Professional fees   -    -    3,125    44,962    20,246    5,572    23,371    50,534 
Accounting and legal expense   -    -    7,773    104    63,000    500    70,773    604 
Technology expense   -    53,910    20,611    83,659    9,464    13,989    30,075    151,558 
General and administrative   -    33,873    3,762    10,761    32,830    47,945    36,592    92,579 
Total operating expense   -    142,722    35,271    139,486    581,837    248,825    617,108    531,033 
                                         
Operating loss from discontinued operations   -    (122,298)   (35,271)   (139,486)   (525,737)   (363,212)   (561,008)   (624,996)
                                         
Other income (expense)                                        
Gain (loss) on disposal of assets   (352,244)   -    (1,783,209)   1,900    (1,426,567)   -    (3,562,020)   1,900 
Total other income (expense)   (352,244)   -    (1,783,209)   1,900    (1,426,567)   -    (3,562,020)   1,900 
                                         
Loss from discontinued operations  $(352,244)  $(122,298)  $(1,818,480)  $(137,586)  $(1,952,304)  $(363,212)  $(4,123,028)  $(623,096)
                                         
Loss per common share from discontinued operations                                        
Basic  $(0.50)  $(0.22)  $(2.57)  $(0.25)  $(2.76)  $(0.66)  $(5.82)  $(1.14)
Diluted  $(0.15)  $(0.22)  $(0.79)  $(0.25)  $(0.85)  $(0.66)  $(1.79)  $(1.14)